$SPOK

Woods-Keisling Sharon sold $226K of SPOK

Woods-Keisling Sharon (Corporate Secretary, Treasurer) sold 20,000 shares of Spok Holdings, Inc (SPOK) at $11.30 ($0.23M total) on 2026-08-10.

Original reporting
SEC EDGAR · Woods-Keisling Sharon
Published Aug 11, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SPOK
Neutral
low confidence
Mentioned
$SPOK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SPOKNeutralLow
01

Why it matters

The newest fact is the specific sale size, price, and post-transaction holdings by an officer (Corporate Secretary, Treasurer).

02

Market read

Traders may note the insider sale as a minor sentiment datapoint, but there is no accompanying operational or financial update.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional context or follow-on filings, signal quality is low.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-11 after-hours; transaction dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for Spok Holdings, Inc.

Company-level read

Ticker impact

$SPOKNeutralLow confidence
Context

Spok Holdings disclosed via Form 4 that officer Woods-Keisling Sharon sold 20,000 shares at $11.2970 on 2026-08-10.

Expected impact

Likely limited near-term impact; any effect would be small and short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying company news, so it rarely drives sustained repricing by itself.

Market effects

No clear sector read-through from a single insider sale at a small disclosed value.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as discretionary selling, but the article provides no reason or pattern beyond this single transaction.

Key entities

  • Spok Holdings, Inc

    Subject of the Form 4 insider transaction disclosure.

  • Woods-Keisling Sharon

    Corporate Secretary and Treasurer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SPOKMed

Spok Reports Second Quarter 2026 Results

Spok Holdings, Inc (SPOK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE CONTACT: Al Galgano 952-224-6096 al.galgano@spok.com Spok Reports Second Quarter 2026 Results Company Generates $4.1 Million of Net Income and $9.1 Million of Adjusted EBITDA Software Operations Bookings Up Nearly 92% From the Prior Quarter Executes Agre

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).